IQVIA Holdings Overview
- Year Founded
-
1982
- Status
-
Public
- Employees
-
95,000
- Stock Symbol
-
IQV
- Investments
-
125
- Share Price
-
$250.55
- (As of Thursday Closing)
IQVIA Holdings General Information
Description
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Contact Information
Website
www.iqvia.comCorporate Office
- 2400 Ellis Road
- Durham, NC 27703
- United States
Corporate Office
- 2400 Ellis Road
- Durham, NC 27703
- United States
IQVIA Holdings Timeline
IQVIA Holdings Stock Performance
As of 19-Nov-2026, IQVIA Holdings’s stock price is $250.55. Its current market cap is $41.3B with 165M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $250.55 | $257.84 | $154.50 - $284.50 | $41.3B | 165M | 1.45M | $8.31 |
IQVIA Holdings Financials Summary
As of 30-Sep-2026, IQVIA Holdings has a trailing 12-month revenue of $17.3B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 58,543,710 | 51,733,323 | 47,654,565 | 54,742,850 |
| Revenue | 17,311,000 | 16,310,000 | 15,405,000 | 14,984,000 |
| EBITDA | 3,515,000 | 3,419,000 | 3,406,000 | 3,220,000 |
| Net Income | 1,394,000 | 1,360,000 | 1,373,000 | 1,358,000 |
| Total Assets | 30,474,000 | 29,944,000 | 26,899,000 | 26,681,000 |
| Total Debt | 16,314,000 | 15,949,000 | 14,156,000 | 13,896,000 |
IQVIA Holdings Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
IQVIA Holdings Comparisons
Industry
Financing
Details
IQVIA Holdings Competitors (28)
One of IQVIA Holdings’s 28 competitors is Syneos Health, a Private Equity-Backed company based in Morrisville, NC.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Syneos Health | Private Equity-Backed | Morrisville, NC | ||||
| Certara | Formerly PE-Backed | Radnor, PA | ||||
| Icon (Dublin) | Corporation | Dublin, Ireland | ||||
| Premier Research | Private Equity-Backed | Morrisville, NC | ||||
| Veeva Systems | Formerly VC-backed | Pleasanton, CA |
IQVIA Holdings Signals
IQVIA Holdings Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
IQVIA Holdings Investments & Acquisitions (125)
IQVIA Holdings’s most recent deal was a Merger/Acquisition with Reverba Global. The deal was made on 01-Oct-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Reverba Global | 01-Oct-2026 | Merger/Acquisition | Enterprise Systems (Healthcare) | ||
| ZephyRx | 01-Aug-2026 | Merger/Acquisition | Other Healthcare Technology Systems | ||
| Charles River Laboratories International (European Discovery Services Assets) | 25-Feb-2026 | Corporate Asset Purchase | Buildings and Property | ||
| Cedar Gate Technologies | 01-Dec-2025 | Merger/Acquisition | Enterprise Systems (Healthcare) | ||
| Throtle | 13-Nov-2025 | Merger/Acquisition | Media and Information Services (B2B) |
IQVIA Holdings ESG
Risk Overview
Risk Rating
Updated November, 17, 2026
17.13 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Laboratory Equipment and Services
Subindustry
of 67
Rank
Percentile
IQVIA Holdings Exits (17)
IQVIA Holdings’s most recent exit was on 13-Feb-2018 from COTA. The exit was categorized as with 7 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| COTA | 13-Feb-2018 | Completed |
|
||
| HighPoint Solutions | 02-Oct-2017 | Completed |
|
||
| Encore Health Resources | 01-Jul-2014 | Completed |
|
||
| EUSA Pharma (UK) | 14-Mar-2008 | Completed |
|
||
| EUSA Pharma (UK) | 01-Mar-2007 | PE Growth/Expansion | Completed |
|
IQVIA Holdings Affiliates
Subsidiaries (42)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Lasso Marketing | Austin, TX | 2019 | |
| Radar Acquisition Blocker | Durham, NC | 2019 | |
| ZephyRx | Troy, NY | 2019 | |
| Next Oncology | San Antonio, TX | 2018 | |
| COGVIO | Prague, Czech Republic | 2017 |
IQVIA Holdings FAQs
-
When was IQVIA Holdings founded?
IQVIA Holdings was founded in 1982.
-
Where is IQVIA Holdings headquartered?
IQVIA Holdings is headquartered in Durham, NC.
-
What is the size of IQVIA Holdings?
IQVIA Holdings has 95,000 total employees.
-
What industry is IQVIA Holdings in?
IQVIA Holdings’s primary industry is Other Healthcare Services.
-
Is IQVIA Holdings a private or public company?
IQVIA Holdings is a Public company.
-
What is IQVIA Holdings’s stock symbol?
The ticker symbol for IQVIA Holdings is IQV.
-
What is the current stock price of IQVIA Holdings?
As of 19-Nov-2026 the stock price of IQVIA Holdings is $250.55.
-
What is the current market cap of IQVIA Holdings?
The current market capitalization of IQVIA Holdings is $41.3B.
-
What is IQVIA Holdings’s current revenue?
The trailing twelve month revenue for IQVIA Holdings is $17.3B.
-
Who are IQVIA Holdings’s competitors?
Syneos Health, Certara, Icon (Dublin), Premier Research, and Veeva Systems are some of the 28 competitors of IQVIA Holdings.
-
What is IQVIA Holdings’s annual earnings per share (EPS)?
IQVIA Holdings’s EPS for 12 months was $8.31.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process